Citable filing context
NDSN's research view summarizes recent SEC filing context, starting with earnings from Aug 19, 2026.
| Filed | Item | Context |
|---|---|---|
| Aug 19, 2026 | earnings | Nordson Corporation reported record Q3 fiscal 2026 sales of $818 million and increased its full-year guidance. |
| Jun 3, 2026 | debt_offering | Nordson Corporation established a new commercial paper program with a maximum aggregate amount of $1.2 billion. |
| May 20, 2026 | earnings | Nordson reported record Q2 2026 sales of $741 million and increased its full-year guidance. |
| Aug 19, 2026 | Guidance: adjusted_earnings_per_diluted_share | 11.80 to 12.00 |
| Aug 19, 2026 | Guidance: sales | 3035.00 to 3075.00 |
| May 20, 2026 | Guidance: adjusted_eps | 11.30 to 11.80 |
| May 21, 2026 | mda_quarterly | Nordson Corporation reported six-month sales of $1.41 billion, an 8.6% increase over the prior year, with net income rising 21.1% to $250.7 million. Growth was led by the Advanced Technology Solutions segment, where sales grew 15.7% driven by exceptional demand for electronic dispense systems. The Industrial Precision Solutions segment saw a 9.4% increase, supported by industrial coating, polymer processing, and precision agriculture. Medical and Fluid Solutions grew 2.4%, primarily through engineered fluid solutions. Geographically, the Asia Pacific region exhibited the strongest growth at 16.4%. Operating profit increased 17.4% to $363.6 million, though results were tempered by a $24.0 million loss from a U.S. pension plan settlement involving a group annuity contract with RGA. The company maintains strong liquidity with a $1.2 billion revolving credit facility and utilized operating cash to repay $107 million in debt, repurchase $129 million in common shares, and pay $92 million in dividends. Key risks to future cash flow and liquidity include international conflicts, shifting trade policies, and tariffs. |
| Feb 19, 2026 | mda_quarterly | Nordson reported sales of $669.5 million for the quarter ended January 31, 2026, an 8.8% increase over the prior year, with net income rising 40.9% to $133.4 million. Growth was led by the Advanced Technology Solutions segment, where sales grew 23.1% driven by strong electronics dispense demand and recovering x-ray system sales. Industrial Precision Solutions sales increased 8.8%, bolstered by strength in Asia Pacific, although segment EBITDA margins declined 380 basis points due to unfavorable product and geographic mix. Medical and Fluid Solutions saw EBITDA margins expand 310 basis points, aided by the divestiture of its contract manufacturing business. Geographically, Asia Pacific sales surged 25.2%, offsetting a 2.2% decline in the Americas. Net income was further enhanced by a $22.2 million unrealized gain on a minority investment and lower interest expenses from reduced average debt. The company utilized its cash flow to execute $86 million in share repurchases and pay $46 million in dividends, supported by a $1.2 billion revolving credit facility. Primary risks include volatility in currency exchange rates and the potential impact of U.S. trade policies, tariffs, and geopolitical unrest in Europe and the Middle East. |
Source: SEC EDGAR filing text and events; period Aug 19, 2026; filed Aug 19, 2026.
NDSN company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.